Stay 
Trading Conditions
Products
Tools
Israel's Teva Pharmaceuticals is considering cutting as many as 6,000 jobs or approximately 11 percent of its global workforce, Isaraeli news site Calcalist reported.
A spokesman for the company refused to give comment.
Teva, the largest Israeli public company, has had a rough year with costly acquisitions, along with delayed drug launches, sending its stock down 72 percent to $32.61. That forced Erez Vigodman to resign as CEO in February.
